Will Thailand impose limits on AstraZeneca vaccine exports?

Question

Accepted Answer

Thailand Is Considering Limits on AstraZeneca Vaccine Exports

Thailand is considering imposing limits on the export of locally manufactured AstraZeneca Covid-19 vaccine doses as a measure to combat its domestic outbreak. This consideration comes amidst the country's most severe Covid-19 surge to date, which has led to record daily fatalities and a significant number of new infections. The country is aiming to secure more vaccine doses to address its own needs.
Efforts to Increase Domestic Supply

The Thai government is seeking to increase its allocation of AstraZeneca vaccines, with Deputy Health Minister Sathit Pitutacha stating that negotiations will be held with the company for more doses. The current production capacity at AstraZeneca's facility in Thailand is reported to be 15 million doses per month, with a potential for future expansion.
Impact of Delivery Delays

AstraZeneca has requested an extension of five months for the delivery of 61 million doses of its Covid-19 vaccine to Thailand. This request, if granted, could further impede the country's already slow vaccination programme. Approximately 5% of Thailand's population of over 66 million has been fully vaccinated.
Current Covid-19 Situation in Thailand

The country is grappling with its worst Covid-19 outbreak, reporting a record 98 coronavirus deaths on July 15, bringing the total number of fatalities to 3,032 since the pandemic began. The Covid-19 taskforce also announced 9,186 new cases on the same day, raising the total number of infections to 372,215.

Reading history

Hide →

This history is cleared when the page is closed.

Will Thailand impose limits on AstraZeneca vaccine exports?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends